M&T Bank Corp Boston Scientific Corp Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, M&T Bank Corp holds 106,127 shares of BSX stock, worth $10.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

106,127

Previous 106,127 -0.0%

Holding current value

$10.9 Million

Previous $8.89 Million -0.0%

% of portfolio

0.03%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$72.96 - $84.0 $26,995 - $31,080	370 Added 0.35%	106,127 $8.89 Million
Q2 2024 Jul 31, 2024	BUY	$67.33 - $77.71 $409,770 - $472,943	6,086 Added 6.11%	105,757 $8.14 Million
Q1 2024 May 07, 2024	SELL	$57.6 - $68.62 $110,880 - $132,093	-1,925 Reduced 1.89%	99,671 $6.83 Million
Q4 2023 Feb 06, 2024	SELL	$48.64 - $57.81 $140,423 - $166,897	-2,887 Reduced 2.76%	101,596 $5.87 Million
Q3 2023 Nov 02, 2023	SELL	$50.19 - $54.68 $126,779 - $138,121	-2,526 Reduced 2.36%	104,483 $5.52 Million
Q2 2023 Aug 09, 2023	SELL	$49.72 - $54.64 $152,739 - $167,854	-3,072 Reduced 2.79%	107,009 $5.79 Million
Q1 2023 May 11, 2023	BUY	$45.09 - $50.03 $1.01 Million - $1.12 Million	22,347 Added 25.47%	110,081 $5.51 Million
Q4 2022 Feb 13, 2023	BUY	$39.56 - $47.22 $269,957 - $322,229	6,824 Added 7.34%	99,830 $4.62 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $478,517 - $571,173	-12,096 Reduced 12.12%	87,734 $4.06 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $32,855 - $98,145	-895 Reduced 0.95%	93,006 $3.58 Million
Q2 2022 Aug 05, 2022	BUY	$35.24 - $47.1 $85,421 - $114,170	2,424 Added 2.65%	93,901 $3.46 Million
Q1 2022 May 09, 2022	SELL	$40.9 - $45.1 $492,476 - $543,049	-12,041 Reduced 11.63%	91,477 $4.05 Million
Q4 2021 Feb 07, 2022	SELL	$38.07 - $44.87 $319,711 - $376,818	-8,398 Reduced 7.5%	103,518 $4.4 Million
Q3 2021 Oct 28, 2021	BUY	$41.23 - $45.88 $12,781 - $14,222	310 Added 0.28%	111,916 $4.86 Million
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $288,616 - $330,959	-7,481 Reduced 6.28%	111,606 $4.77 Million
Q1 2021 May 06, 2021	BUY	$35.27 - $39.67 $576,523 - $648,445	16,346 Added 15.91%	119,087 $4.6 Million
Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $497,051 - $629,298	-14,994 Reduced 12.74%	102,741 $3.69 Million
Q3 2020 Nov 06, 2020	SELL	$34.44 - $42.23 $78,454 - $96,199	-2,278 Reduced 1.9%	117,735 $4.5 Million
Q2 2020 Jul 29, 2020	BUY	$30.19 - $39.11 $30,220 - $39,149	1,001 Added 0.84%	120,013 $4.21 Million
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $3,306 - $5,850	128 Added 0.11%	119,012 $3.88 Million
Q4 2019 Feb 07, 2020	BUY	$37.87 - $45.37 $60,402 - $72,365	1,595 Added 1.36%	118,884 $5.38 Million
Q3 2019 Nov 12, 2019	BUY	$40.31 - $43.45 $50,387 - $54,312	1,250 Added 1.08%	117,289 $4.77 Million
Q2 2019 Aug 12, 2019	BUY	$34.91 - $42.98 $10,577 - $13,022	303 Added 0.26%	116,039 $4.99 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $321,859 - $398,535	9,780 Added 9.23%	115,736 $4.44 Million
Q4 2018 Feb 01, 2019	BUY	$31.73 - $39.04 $313,016 - $385,129	9,865 Added 10.27%	105,956 $3.75 Million
Q3 2018 Nov 09, 2018	SELL	$32.83 - $38.63 $294,911 - $347,013	-8,983 Reduced 8.55%	96,091 $3.7 Million
Q2 2018 Aug 10, 2018	SELL	$26.84 - $34.32 $16,721 - $21,381	-623 Reduced 0.59%	105,074 $3.44 Million
Q1 2018 May 04, 2018	BUY	$25.2 - $28.54 $200,289 - $226,835	7,948 Added 8.13%	105,697 $2.89 Million
Q4 2017 Feb 06, 2018	BUY	$24.79 - $29.8 $215,375 - $258,902	8,688 Added 9.76%	97,749 $2.42 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $209,922 - $233,184	7,994 Added 9.86%	89,061 $2.6 Million
Q2 2017 Aug 11, 2017	BUY	N/A	81,067	81,067 $2.25 Million

Others Institutions Holding BSX

# of Institutions

1,574

Shares Held

1.18B

Call Options Held

6.82M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $146B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account